世界中医药学会联合会分支机构标准《雷公藤多苷片治疗慢性肾脏病合理用药指南》发布公告

       世界中医药学会联合会批准临床用药安全研究专业委员会提交的《雷公藤多苷片治疗慢性肾脏病合理用药指南》分支机构标准（SCM-C 0068-2025）发布，现予公告。

       The SCM-C standard (SCM-C 0068-2025) of Guidelines for rational use of Tripterygium Wilfordii Polyglycosides Tablet in the treatment of chronic kidney disease proposed by Specialty Committee of Research on Safety of Clinical Usage of Drugs of WFCMS was approved by World Federation of Chinese Medicine Societies and was officially issued.